Literature DB >> 15454252

Protein kinase C alpha expression in normal breast, ductal carcinoma in situ and invasive ductal carcinoma.

P D Ainsworth1, J H R Winstanley, J M Pearson, H M Bishop, D R Garrod.   

Abstract

The purpose of this study was to determine if Protein Kinase C alpha (PKC alpha) is altered in expression or localisation in normal breast, ductal carcinoma in situ (DCIS) and invasive ductal carcinoma (IDC). We obtained 14 mixed cases of invasive ductal carcinoma (IDC) and DCIS, 36 pure DCIS cases and 25 cases of normal breast. The sections were stained immunohistochemically for PKC alpha expression. Staining was cytoplasmic. The results showed a progressive reduction in staining intensity from normal breast to invasive ductal carcinoma. The staining pattern was heterogeneous in the cytoplasm of DCIS and IDC, but homogeneous in the cytoplasm of normal breast ductal epithelium. Interestingly, mitotic cells and cells with aberrant nuclear morphology showed increased cytoplasmic staining in DCIS and IDC. PKC alpha activity is altered in dividing or abnormal cells, but overall expression is reduced in IDC. This raises the possibility of an alteration in the subcellular localisation of PKC alpha which may relate to changes in desmosomal adhesive state.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15454252     DOI: 10.1016/j.ejca.2004.06.027

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  11 in total

1.  Involvement of PKCα activation in TF/VIIa/PAR2-induced proliferation, migration, and survival of colon cancer cell SW620.

Authors:  Biao Wu; Hong Zhou; Lichao Hu; Yuan Mu; Ying Wu
Journal:  Tumour Biol       Date:  2012-12-12

2.  PKCalpha expression is a marker for breast cancer aggressiveness.

Authors:  Gry Kalstad Lønne; Louise Cornmark; Iris Omanovic Zahirovic; Göran Landberg; Karin Jirström; Christer Larsson
Journal:  Mol Cancer       Date:  2010-04-14       Impact factor: 27.401

3.  Expression of protein kinase C family in human hepatocellular carcinoma.

Authors:  Hsiu-Chin Lu; Fen-Pi Chou; Kun-Tu Yeh; Ya-Sian Chang; Nicholas C Hsu; Jan-Gowth Chang
Journal:  Pathol Oncol Res       Date:  2009-12-01       Impact factor: 3.201

4.  Network analysis of the focal adhesion to invadopodia transition identifies a PI3K-PKCα invasive signaling axis.

Authors:  Daisuke Hoshino; Jerome Jourquin; Shane Weller Emmons; Tyne Miller; Margalit Goldgof; Kaitlin Costello; Darren R Tyson; Brandee Brown; Yiling Lu; Nagendra K Prasad; Bing Zhang; Gordon B Mills; Wendell G Yarbrough; Vito Quaranta; Motoharu Seiki; Alissa M Weaver
Journal:  Sci Signal       Date:  2012-09-11       Impact factor: 8.192

Review 5.  The complexities of PKCα signaling in cancer.

Authors:  Adrian R Black; Jennifer D Black
Journal:  Adv Biol Regul       Date:  2020-11-23

6.  The protein kinase C agonist PEP005 (ingenol 3-angelate) in the treatment of human cancer: a balance between efficacy and toxicity.

Authors:  Elisabeth Ersvaer; Astrid Olsnes Kittang; Peter Hampson; Kristoffer Sand; Bjørn Tore Gjertsen; Janet M Lord; Oystein Bruserud
Journal:  Toxins (Basel)       Date:  2010-01-22       Impact factor: 4.546

Review 7.  Targeting Protein Kinase C Downstream of Growth Factor and Adhesion Signalling.

Authors:  Catríona M Dowling; Patrick A Kiely
Journal:  Cancers (Basel)       Date:  2015-07-15       Impact factor: 6.639

8.  Synthesis and Anticancer Evaluation of Novel Derivatives of Isoxazolo[4,5-e][1,2,4]triazepine Derivatives and Potential Inhibitors of Protein Kinase C.

Authors:  Edwin Wagner; Joanna Wietrzyk; Mateusz Psurski; Lilianna Becan; Eliza Turlej
Journal:  ACS Omega       Date:  2020-12-24

9.  Extranuclear ERα is associated with regression of T47D PKCα-overexpressing, tamoxifen-resistant breast cancer.

Authors:  Bethany Perez White; Mary Ellen Molloy; Huiping Zhao; Yiyun Zhang; Debra A Tonetti
Journal:  Mol Cancer       Date:  2013-05-01       Impact factor: 27.401

10.  Clinicopathological correlation and prognostic significance of protein kinase cα overexpression in human gastric carcinoma.

Authors:  Shee-Chan Lin; Wei-Yu Chen; Kai-Yuan Lin; Sheng-Hsuan Chen; Chun-Chao Chang; Sey-En Lin; Chia-Lang Fang
Journal:  PLoS One       Date:  2013-02-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.